Daunorubicin- and Ara-C-induced interphasic apoptosis of human type II leukemia cells is caspase-8-independent

Anne-Dominique Terrisse1, Christine Bezombes, Sandra Lerouge

  • 1Institut National de la Santé et de la Recherche Médicale E9910, Institut Claudius Régaud, 20 rue Pont St Pierre, 31052 Toulouse, France.

Insights

Drug-induced apoptosis in leukemia cells is initiated by ceramide generation, not caspase-8 cleavage. This finding clarifies the early signaling events in Type II leukemic cells, impacting cancer research.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Interphasic apoptosis in leukemia involves complex intracellular signaling pathways.
  • The precise initiating event for drug-induced apoptosis in Type II cells remains unclear, with both ceramide generation and procaspase-8 cleavage proposed as early steps.

Purpose of the Study:

  • To determine if procaspase-8 cleavage is essential for initial ceramide generation and rapid interphasic apoptosis.
  • To investigate the chronological order of ceramide generation and caspase-8 cleavage induced by daunorubicin (DNR) and 1-beta-D-arabinofuranosylcytosine (Ara-C).

Main Methods:

  • Investigated chronological ordering of ceramide generation and caspase-8 cleavage in U937 cells treated with DNR and Ara-C.
  • Evaluated the impact of DNR and Ara-C on ceramide generation and apoptosis in wild-type Jurkat cells and Jurkat clones mutated for caspase-8 and Fas-associated death domain.

Main Results:

  • Both DNR and Ara-C induced early ceramide generation (5-20 min) and interphasic apoptosis in all tested cell models.
  • Caspase-8 cleavage was observed much later (4.5 h) and only in DNR-treated cells; neither drug induced caspase-8 activation.
  • These findings indicate that caspase-8 cleavage is not required for the initial ceramide-mediated apoptotic pathway.

Conclusions:

  • Procaspase-8 cleavage is not a requisite event for the initiation of drug-induced ceramide-mediated interphasic apoptosis in human Type II leukemic cells.
  • Ceramide generation is the proximal initiating event in this apoptotic pathway, preceding caspase-8 involvement.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...